Jasmine Cui, PhDCo-Founder, President and CEO at InnoCare
Dr. Jasmine Cui is the founder, President & CEO of InnoCare Pharma Ltd. InnoCare is a biopharmaceutical company rooted in China with the global vision to discover and develop novel treatment for cancer and autoimmune diseases.
Prior to founding InnoCare, Dr. Cui was the General Manager of BioDuro (2011-2015), responsible for BioDuro’s overall scientific and operational management, as well as business & resource management. Before BioDuro, Dr. Cui worked at Merck Research Laboratories for 14 years serving as Director of Cardiovascular Diseases where she provided project leadership for delivering more than 10 drug candidates. She also served as the Chair of Early Development Team for development of drug candidates from preclinical to clinical phase 2a for POC in humans. Additionally, she headed the hypertension exploratory biomarker department for identifying and developing preclinical and translatable biomarkers in cardiovascular diseases.
Dr. Cui received her Ph.D. in biology from Purdue University and completed her postdoctoral fellowship at Howard Hughes Medical Institute affiliated with the University of Michigan. Dr. Cui was the 17th SAPA President and now serves as the President of SAPA China.